New HIV Prevention R&D Report Highlights 2000-2014 Global Funding Trends

Global Health Technologies Coalition’s “Breakthroughs”: New report on investment in R&D for HIV prevention highlights 2014 global funding trends
In a guest post, the HIV Vaccines & Microbicides Resource Tracking Working Group discusses a new report examining HIV prevention research and development funding trends from 2000 to 2014. “Through their research and analysis, the Working Group identified four key findings about the state of funding for HIV prevention R&D which are highlighted in the report: R&D investment is expanding beyond research to rollout. … Majority of investment is from several large funders. … Decrease in number of philanthropic funders engaged. … Development funding priorities are changing” (7/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.